New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic ...

Jemperli is the only immuno-oncology agent to demonstrate a survival benefit in this patient population, according to GSK, and is a key approval for the drug as it fends off a challenge in ...

GSK's decision comes during a buoyant period for the UK life sciences sector, which attracted a record £1.6 billion ($2.2 billion) in financing in the three months to end-May, ranking third ...